October 16, 2006 — The European Commission has approved pregabalin capsules for the treatment of central neuropathic pain associated with spinal cord injury, stroke, and multiple sclerosis; and ...

May 15, 2006 — Health Canada has approved a 500-mg tablet formulation of saquinavir mesylate that significantly reduces the daily pill count for patients with HIV; the European Commission has approved ...

INCHEON, South Korea--(BUSINESS WIRE)--Celltrion today announced two-year results of subcutaneous infliximab (CT-P13 SC) dose escalation therapy at United European Gastroenterology (UEG) Week 2024 in ...

Please provide your email address to receive an email when new articles are posted on . The FDA has granted de novo clearance to ProciseDx Inc. for its therapeutic drug monitoring tests for Humira and ...

Subcutaneous infliximab injection Remsima SC is towing Celltrion’s revenue in 2020, according to the company, Friday. Despite the COVID-19 scare dampening the global economy, Celltrion said in a ...

Psoriatic arthritis (PsA) is a chronic condition, and ongoing treatment is needed to prevent permanent joint damage. The right treatment can also ease the number of arthritis flare-ups. Biologics are ...